Penn Capital Management Company, LLC Axogen, Inc. Transaction History

Penn Capital Management Company, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$8.38 - $17.34 $1.31 Million - $2.71 Million	-156,231 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$11.18 - $18.6 $666,641 - $1.11 Million	-59,628 Reduced 27.62%	156,231 $2.8 Million
Q3 2019 Nov 13, 2019	BUY	$12.09 - $20.46 $12,247 - $20,725	1,013 Added 0.47%	215,859 $2.69 Million
Q1 2019 May 06, 2019	BUY	$14.62 - $22.13 $2.15 Million - $3.26 Million	147,232 Added 217.75%	214,846 $4.53 Million
Q4 2018 Feb 19, 2019	BUY	$17.09 - $38.25 $1.16 Million - $2.59 Million	67,614 New	67,614 $1.38 Million

176

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $749M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Penn Capital Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Penn Capital Management Company, LLC with notifications on news.